0
18
Journal Articles about Antipsychotics Showing 41-60 of 289
Brief Report | April 01, 2009
Psychiatric Illness and Obesity: Recognizing the "Obesogenic" Nature of an Inpatient Psychiatric Setting
Guy E. J. Faulkner, M.Sc., Ph.D.; Paul F. Gorczynski, B.H.Sc., M.A.; Tony A. Cohn, M.B.Ch.B., M.Sc.
Psychiatric Services. 2009 April ; 4(60):538-541
PDFPDF
Column | March 01, 2009
Best Practices: An Intervention to Promote Evidence-Based Prescribing at a Large Psychiatric Hospital
Keith R. Stowell, M.D., M.S.P.H.; Frank A. Ghinassi, Ph.D.; Tanya J. Fabian, Ph.D., Pharm.D.; Kenneth C. Nash, M.D.; Roger F. Haskett, M.D.
Psychiatric Services. 2009 March ; 3(60):294-296
PDFPDF
Article | February 01, 2009
Adherence to Antipsychotics Among Latinos and Asians With Schizophrenia and Limited English Proficiency
Todd P. Gilmer, Ph.D.; Victoria D. Ojeda, Ph.D., M.P.H.; Concepcion Barrio, Ph.D.; Dahlia Fuentes, M.P.H., M.S.W.; Piedad Garcia, Ed.D., L.C.S.W.; Nicole M. Lanouette, M.D.; Kelly C. Lee, Pharm.D.
Psychiatric Services. 2009 February ; 2(60):175-182
PDFPDF
Article | October 01, 2008
Changing Trends in Pediatric Antipsychotic Use in Florida's Medicaid Program
Robert Constantine, Ph.D.; Rajiv Tandon, M.D.
Psychiatric Services. 2008 October ; 10(59):1162-1168
PDFPDF
Article | October 01, 2008
Trends in Use of Antipsychotics and Mood Stabilizers Among Medicaid Beneficiaries With Bipolar Disorder, 2001–2004
Colin Depp, Ph.D.; Victoria D. Ojeda, Ph.D., M.P.H.; William Mastin, Pharm.D.; Jürgen Unützer, M.D., M.P.H.; Todd P. Gilmer, Ph.D.
Psychiatric Services. 2008 October ; 10(59):1169-1174
  Supplemental Content
Brief Report | October 01, 2008
Dosing Frequency and Adherence to Antipsychotic Medications
Paul N. Pfeiffer, M.D.; Dara Ganoczy, M.P.H.; Marcia Valenstein, M.D.
Psychiatric Services. 2008 October ; 10(59):1207-1210
PDFPDF  |    Supplemental Content
Column | July 01, 2008
Datapoints: Polypharmacy as the Initial Second-Generation Antipsychotic Treatment
Brason Lee, M.S.W., M.S.; Victor Walker, B.S.
Psychiatric Services. 2008 July ; 7(59):717-717
PDFPDF
Taking Issue | May 01, 2008
Lessons to Be Learned From CATIE and CUtLASS
Beverly Jewell Sutton, M.D.
Psychiatric Services. 2008 May ; 5(59):473-473
PDFPDF
Column | May 01, 2008
Datapoints: Did CATIE Influence Antipsychotic Use?
Leslie Citrome, M.D., M.P.H.; Ari Jaffe, M.D.; David Martello; Baerbel Allingham, M.S.; Jerome Levine, M.D.
Psychiatric Services. 2008 May ; 5(59):476-476
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Introduction to the CATIE Special Section
Marvin S. Swartz, M.D.
Psychiatric Services. 2008 May ; 5(59):497-499
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
Marvin S. Swartz, M.D.; T. Scott Stroup, M.D., M.P.H.; Joseph P. McEvoy, M.D.; Sonia M. Davis, Dr.P.H.; Robert A. Rosenheck, M.D.; Richard S. E. Keefe, Ph.D.; John K. Hsiao, M.D.; Jeffrey A. Lieberman, M.D.
Psychiatric Services. 2008 May ; 5(59):500-506
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?
Marisa Elena Domino, Ph.D.; Marvin S. Swartz, M.D.
Psychiatric Services. 2008 May ; 5(59):507-514
PDFPDF  |    Supplemental Content
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making
Robert A. Rosenheck, M.D.; Douglas L. Leslie, Ph.D.; Jalpa A. Doshi, Ph.D.
Psychiatric Services. 2008 May ; 5(59):515-520
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Policy Toward Second-Generation Antipsychotic Drugs: A Cautionary Note
Richard G. Frank, Ph.D.
Psychiatric Services. 2008 May ; 5(59):521-522
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Lessons to Take Home From CATIE
William T. Carpenter, M.D.; Robert W. Buchanan, M.D.
Psychiatric Services. 2008 May ; 5(59):523-525
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Implications of CATIE for Mental Health Services Researchers
Nancy H. Covell, Ph.D.; Molly T. Finnerty, M.D.; Susan M. Essock, Ph.D.
Psychiatric Services. 2008 May ; 5(59):526-529
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: What CATIE Did: Some Thoughts on Implications Deep and Wide
David Cunningham Owens, M.D., F.R.C.Psych.
Psychiatric Services. 2008 May ; 5(59):530-533
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: Impact of the CATIE Findings on State Mental Health Policy
Joseph J. Parks, M.D.; Alan Q. Radke, M.D.; Rajiv Tandon, M.D.
Psychiatric Services. 2008 May ; 5(59):534-536
PDFPDF
Special Section on Implications of CATIE | May 01, 2008
Special Section on Implications of CATIE: NAMI Perspective on CATIE: Policy and Research Implications
Kenneth Duckworth, M.D.; Michael J. Fitzpatrick, M.S.W.
Psychiatric Services. 2008 May ; 5(59):537-539
PDFPDF
Other Articles | May 01, 2008
Effect of Prior Authorization of Second-Generation Antipsychotic Agents on Pharmacy Utilization and Reimbursements
Michael R. Law, M.Sc.; Dennis Ross-Degnan, Sc.D.; Stephen B. Soumerai, Sc.D.
Psychiatric Services. 2008 May ; 5(59):540-546
PDFPDF
Copyright ©
American
Psychiatric
Association